BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27975051)

  • 1. Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt.
    He F; Dai S; Xiao Z; Wang L; Yue Z; Zhao H; Zhao M; Lin Q; Dong X; Liu F
    Biomed Res Int; 2016; 2016():3681731. PubMed ID: 27975051
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.
    Deng D; Liao MS; Qin JP; Li XA
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):232-6. PubMed ID: 16698582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.
    Fonio P; Discalzi A; Calandri M; Doriguzzi Breatta A; Bergamasco L; Martini S; Ottobrelli A; Righi D; Gandini G
    Radiol Med; 2017 Sep; 122(9):713-721. PubMed ID: 28510807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
    World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory hepatic encephalopathy due to concomitant transjugular intrahepatic portosystemic shunt and spontaneous mesocaval shunt controlled by embolization of the competitive portosystemic shunt.
    Cura M
    Clin Imaging; 2009; 33(3):231-3. PubMed ID: 19411031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision.
    Rowley MW; Choi M; Chen S; Hirsch K; Seetharam AB
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1765-1772. PubMed ID: 29872892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy.
    Pereira K; Carrion AF; Martin P; Vaheesan K; Salsamendi J; Doshi M; Yrizarry JM
    Liver Int; 2015 Dec; 35(12):2487-94. PubMed ID: 26332169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Riggio O; Nardelli S; Moscucci F; Pasquale C; Ridola L; Merli M
    Clin Liver Dis; 2012 Feb; 16(1):133-46. PubMed ID: 22321469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury.
    Bhatia Kapoor P; Benjamin J; Tripathi H; Patidar Y; Maiwall R; Kumar G; Joshi YK; Sarin SK
    Turk J Gastroenterol; 2023 Apr; 34(4):406-412. PubMed ID: 36620928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation.
    Kloster ML; Ren A; Shah KY; Alqadi MM; Bui JT; Lipnik AJ; Niemeyer MM; Ray CE; Gaba RC
    Dig Dis Sci; 2021 Nov; 66(11):4058-4062. PubMed ID: 33236314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Portosystemic shunt via the left branch of portal vein for the prevention of encephalopathy following transjugular intrahepatic portosystemic shunt].
    Chu J; Sun X; Piao L; Chen Z; Huang H; Lu C; Xu J
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):437-40. PubMed ID: 12502447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model to predict early hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt.
    Li Y; He X; Pang H
    Turk J Gastroenterol; 2019 Aug; 30(8):702-707. PubMed ID: 31418414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation.
    Charon JP; Alaeddin FH; Pimpalwar SA; Fay DM; Olliff SP; Jackson RW; Edwards RD; Robertson IR; Rose JD; Moss JG
    J Vasc Interv Radiol; 2004 Nov; 15(11):1219-30. PubMed ID: 15525740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
    Berres ML; Lehmann J; Jansen C; Görtzen J; Meyer C; Thomas D; Zimmermann HW; Kroy D; Schumacher F; Strassburg CP; Sauerbruch T; Trautwein C; Wasmuth HE; Trebicka J
    Liver Int; 2016 Mar; 36(3):386-94. PubMed ID: 26212075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Based on CT Radiomic Features of Visceral Adipose Tissue.
    Cheng S; Hu G; Jin Z; Wang Z; Xue H
    Acad Radiol; 2024 May; 31(5):1849-1861. PubMed ID: 38007366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study.
    Maleux G; Heye S; Verslype C; Nevens F
    J Vasc Interv Radiol; 2007 Aug; 18(8):986-92; quiz 993. PubMed ID: 17675616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.